Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
LISOCABTAGENE (BREYANZI) INJ (OTHER 63635130) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 29, 2026 , from http://ppman.hank.ai/transparency/procedure/63635130/by-state?code_type=OTHER
“LISOCABTAGENE (BREYANZI) INJ (OTHER 63635130) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/63635130/by-state?code_type=OTHER. Accessed
October 29, 2026 .
“LISOCABTAGENE (BREYANZI) INJ (OTHER 63635130) by State,” HANK Price Transparency ,
accessed October 29, 2026 ,
http://ppman.hank.ai/transparency/procedure/63635130/by-state?code_type=OTHER.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
OTHER · across United States
63635130 — Lisocabtagene (breyanzi) Inj
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$650,230
National median
$546,459 – $752,675
IQR (p25 – p75)
8
hospitals filing
2
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 63635130 (OTHER), with interquartile range
State Median p25 p75
DC $759,741 $562,201 $1,752,832
MD $650,230 $546,459 $752,675